CABALETTA BIO, INC. (CABA): Price and Financial Metrics
CABA Price/Volume Stats
Current price | $1.63 | 52-week high | $8.77 |
Prev. close | $1.60 | 52-week low | $0.99 |
Day low | $1.56 | Volume | 930,400 |
Day high | $1.63 | Avg. volume | 1,618,338 |
50-day MA | $1.68 | Dividend yield | N/A |
200-day MA | $2.51 | Market Cap | 82.71M |
CABA Stock Price Chart Interactive Chart >
CABALETTA BIO, INC. (CABA) Company Bio
Cabaletta Bio, Inc. operates as a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies. The company was founded by Michael C. Milone, Steven Nichtberger, and Aimee Payne in 2017 and is headquartered in Philadelphia, PA.
CABA Price Returns
1-mo | -34.27% |
3-mo | 42.36% |
6-mo | -39.41% |
1-year | -76.88% |
3-year | 13.19% |
5-year | -85.46% |
YTD | -28.19% |
2024 | -90.00% |
2023 | 145.41% |
2022 | 144.06% |
2021 | -69.63% |
2020 | -10.67% |
Loading social stream, please wait...